AMPWP
ABBV icon

Alvarez & Marsal Private Wealth Partners’s AbbVie ABBV Stock Holding History

Alvarez & Marsal Private Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Sell
1,850
-3,776
-67% -$812K 0.06% 54
2026
Q1 		$1.22M Buy
5,626
+2,428
+76% +$539K 0.17% 36
2025
Q4 		$731K Buy
+3,198
New +$729K 0.14% 36

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alvarez & Marsal Private Wealth Partners's ABBV Position: Q2 2026 in Review

Alvarez & Marsal Private Wealth Partners reduced its AbbVie (ABBV) stake by 67% in Q2 2026, selling an estimated $812K and leaving 1,850 shares worth $466K. The position accounts for 0.06% of the portfolio, ranked #54.

Alvarez & Marsal Private Wealth Partners first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.22M in Q1 2026. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Alvarez & Marsal Private Wealth Partners held 1,850 shares of AbbVie worth $466K as of Q2 2026.
  • Alvarez & Marsal Private Wealth Partners sold 3,776 AbbVie shares in Q2 2026, an estimated $812K.
  • AbbVie made up 0.06% of Alvarez & Marsal Private Wealth Partners's portfolio in Q2 2026, its #54 holding.
  • Alvarez & Marsal Private Wealth Partners first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Alvarez & Marsal Private Wealth Partners's AbbVie position peaked at $1.22M in Q1 2026.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alvarez & Marsal Private Wealth Partners's 13F filing for Q2 2026, filed 14 Aug 2026.